FDA-cleared profile

Overjet Caries Assist

Overjet, Inc. · X-ray/Radiography · FDA-cleared (510(k))

Authorized purpose: Concurrent-read CADe to aid professionally trained and licensed dentists in detecting and segmenting caries on bitewing and periapical radiographs; the output is additional information and does not replace dentist review or clinical judgment.

Clinical role
Concurrent-read dental CADe for caries detection and segmentation during dentist review; the presentation layer provides a non-diagnostic viewer in which annotations can be filtered, displayed, hidden, created, or edited.
Images and patients
X-ray/Radiography · Permanent dentition and tooth surfaces in dental/maxillofacial anatomy
Key limitation
Keep in mind: Safety and effectiveness were not established on primary or mixed dentition, and use is limited to licensed dentists. The device is not a sole decision-making tool and may produce false-positive or false-negative outputs. Accuracy is not guaranteed for unlisted sensors or images below 500 x 500 resolution; incorrect image rotation can make tooth numbering and caries predictions inaccurate. Significant tooth overlap may suppress predictions unless a radiolucency remains distinctly visible.

Overview status: Source-reviewed overview

Report a correction
Clinical details Purpose, workflow fit, evidence, and safety record

Workflow navigation pilot

Workflow role has not yet been reviewed for this navigation pilot.

A tag identifies a documented role; it does not establish compatibility or local acceptance. Methods and sources

  • What does this software do?Authorized purpose: Concurrent-read CADe to aid professionally trained and licensed dentists in detecting and segmenting caries on bitewing and periapical radiographs; the output is additional information and does not replace dentist review or clinical judgment.
  • Which images or clinical context are in scope?Modality: X-ray/Radiography Anatomy or clinical context: Permanent dentition and tooth surfaces in dental/maxillofacial anatomy Input: Digital bitewing and periapical radiographs of permanent dentition in patients at least 12 years old; images smaller than 500 x 500 resolution are not intended. The packet describes testing with Carestream, Dexis, e2v, Gendex, Hamamatsu, Jazz Imaging, ScanX, Schick, and Soredex Digora sensors and image formats including JPG, PNG, EOP, TIFF, and DICOM.
  • Who uses it?Intended users: Professionally trained and licensed dentists
  • What does the software produce?Output: Caries detection and segmentation on the radiograph, resulting in an outline or fill of suspected caries with predictions assigned to a specific tooth; the packet distinguishes primary, secondary, enamel, and dentin caries outputs.
  • What is its most important limitation?Key limitation: Safety and effectiveness were not established on primary or mixed dentition, and use is limited to licensed dentists. The device is not a sole decision-making tool and may produce false-positive or false-negative outputs. Accuracy is not guaranteed for unlisted sensors or images below 500 x 500 resolution; incorrect image rotation can make tooth numbering and caries predictions inaccurate. Significant tooth overlap may suppress predictions unless a radiolucency remains distinctly visible.

Clinical takeaway. Clinical role: Concurrent-read CADe to aid professionally trained and licensed dentists in detecting and segmenting caries on bitewing and periapical radiographs; the output is additional information and does not replace dentist review or clinical judgment.

Evidence takeaway. Evidence from the reviewed source record: FDA standalone testing evaluated 1,293 bitewing images and 1,314 periapical images, including 27,920 bitewing surfaces and 16,254 periapical surfaces, against consensus labels from three US licensed dentists with oral-radiologist adjudication of non-consensus labels. Overall standalone sensitivity was 76.6% for bitewing images (95% CI 73.8%-79.4%) and 79.4% for periapical images (76.1%-82.8%); specificity was 99.1% for bitewing images (98.9%-99.2%) and 99.4% for periapical images (99.2%-99.5%). A 28-dentist reader study used 330 bitewing and 330 periapical images; assisted reader sensitivity was 78.5% and 79.0%, versus 64.6% and 65.6% unassisted, while assisted specificity was 98.6% and 97.6%, versus 99.0% and 98.0% unassisted.

Evidence context

Evidence context not reviewed for this FDA record.

Public-label constraints

Label constraints have not been reviewed for this exact FDA record. Unknown is not all ages or evidence of unsuitability.

Public-label constraints, not patient-level eligibility or a medical recommendation. Training and evaluation populations are separate. Read the original labeling and confirm the exact release and protocol.

Purpose
Concurrent-read CADe to aid professionally trained and licensed dentists in detecting and segmenting caries on bitewing and periapical radiographs; the output is additional information and does not replace dentist review or clinical judgment.
  • Exact FDA submission
  • Checked 2026-09-08
Workflow role
Concurrent-read dental CADe for caries detection and segmentation during dentist review; the presentation layer provides a non-diagnostic viewer in which annotations can be filtered, displayed, hidden, created, or edited.
  • Exact FDA submission
  • Checked 2026-09-08
Required input
Digital bitewing and periapical radiographs of permanent dentition in patients at least 12 years old; images smaller than 500 x 500 resolution are not intended. The packet describes testing with Carestream, Dexis, e2v, Gendex, Hamamatsu, Jazz Imaging, ScanX, Schick, and Soredex Digora sensors and image formats including JPG, PNG, EOP, TIFF, and DICOM.
  • Exact FDA submission
  • Checked 2026-09-08
Output and clinician action
Caries detection and segmentation on the radiograph, resulting in an outline or fill of suspected caries with predictions assigned to a specific tooth; the packet distinguishes primary, secondary, enamel, and dentin caries outputs.
  • Exact FDA submission
  • Checked 2026-09-08
Care setting
Dental practice or clinic imaging workflow through a practice PACS or EMR; the FDA packet does not identify a more specific facility type.
  • Exact FDA submission
  • Checked 2026-09-08
Intended users
Professionally trained and licensed dentists
  • Exact FDA submission
  • Checked 2026-09-08
Limitations
Safety and effectiveness were not established on primary or mixed dentition, and use is limited to licensed dentists. The device is not a sole decision-making tool and may produce false-positive or false-negative outputs. Accuracy is not guaranteed for unlisted sensors or images below 500 x 500 resolution; incorrect image rotation can make tooth numbering and caries predictions inaccurate. Significant tooth overlap may suppress predictions unless a radiolucency remains distinctly visible.
  • Exact FDA submission
  • Checked 2026-09-08
Evidence summary
FDA standalone testing evaluated 1,293 bitewing images and 1,314 periapical images, including 27,920 bitewing surfaces and 16,254 periapical surfaces, against consensus labels from three US licensed dentists with oral-radiologist adjudication of non-consensus labels. Overall standalone sensitivity was 76.6% for bitewing images (95% CI 73.8%-79.4%) and 79.4% for periapical images (76.1%-82.8%); specificity was 99.1% for bitewing images (98.9%-99.2%) and 99.4% for periapical images (99.2%-99.5%). A 28-dentist reader study used 330 bitewing and 330 periapical images; assisted reader sensitivity was 78.5% and 79.0%, versus 64.6% and 65.6% unassisted, while assisted specificity was 98.6% and 97.6%, versus 99.0% and 98.0% unassisted.
  • Exact FDA submission
  • Checked 2026-09-08

Evidence

Performance evidence

Metrics are shown only when they are tied to a source, endpoint, population, and tested product version. Candidate literature without exact product and version linkage is not shown as product evidence.

Evidence summary
FDA standalone testing evaluated 1,293 bitewing images and 1,314 periapical images, including 27,920 bitewing surfaces and 16,254 periapical surfaces, against consensus labels from three US licensed dentists with oral-radiologist adjudication of non-consensus labels. Overall standalone sensitivity was 76.6% for bitewing images (95% CI 73.8%-79.4%) and 79.4% for periapical images (76.1%-82.8%); specificity was 99.1% for bitewing images (98.9%-99.2%) and 99.4% for periapical images (99.2%-99.5%). A 28-dentist reader study used 330 bitewing and 330 periapical images; assisted reader sensitivity was 78.5% and 79.0%, versus 64.6% and 65.6% unassisted, while assisted specificity was 98.6% and 97.6%, versus 99.0% and 98.0% unassisted.
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-08
Reported sensitivity
Bitewing: 76.6%, Periapical: 79.4%
  • Public source
  • Exact FDA submission
  • Checked 2026-09-01

Model sensitivity reported by ACR AI Central. Review endpoint, threshold, study population, and tested version before comparison.

Reported specificity
Bitewing: 99.1%, Periapical: 99.4%
  • Public source
  • Exact FDA submission
  • Checked 2026-09-01

Model specificity reported by ACR AI Central. Review endpoint, threshold, study population, and tested version before comparison.

No contextualized exact-version metric has completed evidence review. Regulatory-document values, when available, are shown above with their limitations.

Overjet Caries Assist regulatory performance study summary

  • DesignStand-alone performance and reader study (ACR AI Central category)
  • PopulationAdult and Pediatric
  • Scopeexact submission
  • Tested versionExact product version not reported; regulatory study summarized for FDA submission K222746
  • Samplen=2607
  • IndependenceIndependence not established

K222746

ACR AI Central summarizes the regulatory study; consult the exact FDA materials before comparative use.

Safety and lifecycle

Postmarket record

Recall and adverse-event records are shown only after product matching. Adverse-event reports do not establish incidence or causality.

Postmarket safety review
The exact-identifier FDA recall query returned no native recall record for K222746. This limited result does not establish absence of recalls or other safety information and does not cover later versions, family records, MAUDE reports, corrections, or field notices.
  • Public source
  • Exact FDA submission
  • Checked 2026-09-08
Pricing & contracts Public price, contract terms, and reimbursement

Price not public here; enter your quote

Not verified: Pricing information is recorded but not verified against a resolving source.

Reimbursement

IT implementation Deployment, interfaces, data handling, and support

System and version relationships

Match the AI release, system build, configuration and region. Source documentation does not establish acceptance of an installed system.

No specific system/version pairing has completed review for this FDA record. A broad DICOM or product-family statement does not establish a named viewer build's support.

Review Merge, Visage, Sectra, AGFA and IntelePACS context

Integration chain: evidence at each hop

Public source context, not tested interoperability. Each hop needs its own release/configuration evidence. Missing or unavailable routes are not documented incompatibility. All local tests are planned, not passed; no installed-system acceptance is recorded.

Acquisition/source → routing → AI processing → returned objects → viewer/worklist/report → support owner

No specific route context has been source-reviewed for this record. Obtain both endpoint builds and documents; this is not a finding of incompatibility.

  1. Acquisition/source

    Source context, not route validation: Digital bitewing and periapical radiographs of permanent dentition in patients at least 12 years old; images smaller than 500 x 500 resolution are not intended. The packet describes testing with Carestream, Dexis, e2v, Gendex, Hamamatsu, Jazz Imaging, ScanX, Schick, and Soredex Digora sensors and image formats including JPG, PNG, EOP, TIFF, and DICOM.

    Scope: Exact FDA submission.

    Confirm scanner/model, protocol, series completeness and both software builds.

    Field checked 2026-09-08 · FDA K222746: Overjet Caries Assist

  2. Routing

    Source context, not route validation: The network layer works with a practice PACS or EMR to transmit image and metadata to Overjet, and the web presentation layer displays annotations in a non-diagnostic viewer. The reviewed FDA packet does not establish a specific interface version, local compatibility, or current commercial deployment topology.

    Scope: Exact FDA submission.

    Name gateways, destinations, transfer rules and failure visibility; a DICOM statement does not prove a route.

    Field checked 2026-09-08 · FDA K222746: Overjet Caries Assist

  3. AI processing

    Source context, not route validation: The exact FDA package describes a web platform (Edge, Chrome, Firefox) in which images are pulled in from the clinic or dental office and a network layer works with the practice PACS or EMR to transmit images and metadata to Overjet. Current hosting, data flow, and commercial configuration require vendor confirmation.

    Scope: Exact FDA submission. Packet wording: "Platform Web - Edge, Chrome, Firefox Web - Edge, Chrome, Firefox" … "OCA is a software-only device which operates in three layers: a Network Layer, a Presentation Layer, and a Decision Layer. Images are pulled in from a clinic/dental office". Read from the exact FDA decision document on 2026-11-14; this is the release-level description, not current commercial configuration.

    Confirm processing location, queue ownership, exclusions and exact AI build.

    Field checked 2026-11-14 · FDA K222746: Overjet Caries Assist

  4. Returned objects

    Source context, not route validation: Caries detection and segmentation on the radiograph, resulting in an outline or fill of suspected caries with predictions assigned to a specific tooth; the packet distinguishes primary, secondary, enamel, and dentin caries outputs.

    Scope: Exact FDA submission.

    Confirm object classes, units, references and whether findings, overlays or measurements reach their intended destination.

    Field checked 2026-09-08 · FDA K222746: Overjet Caries Assist

  5. Viewer/worklist/report

    Unresolved route: Caries detection and segmentation on the radiograph, resulting in an outline or fill of suspected caries with predictions assigned to a specific tooth; the packet distinguishes primary, secondary, enamel, and dentin caries outputs.

    Scope: Exact FDA submission.

    Confirm the named viewer/worklist/report build, display behavior and report transfer. Output support alone does not establish this endpoint. The displayed source describes output, not validated end-to-end delivery.

    Field checked 2026-09-08 · FDA K222746: Overjet Caries Assist

  6. Support owner

    Unresolved route: Not established for the exact route.

    Scope: Scope not established.

    Name the local, platform and AI supplier support owners and escalation path.

Planned local route tests

No tests below have been performed or accepted.

  1. Patient/study identity (planned). Use approved non-patient test data to verify identifiers, accession and result-to-study linkage at every hop.
  2. Study completeness (planned). Test missing views/series, partial transfer, late arrivals, priors and unsupported acquisition inputs; confirm explicit refusal or fallback.
  3. Ordering and duplicates (planned). Send out-of-order, repeated and corrected studies; verify worklist order, deduplication and no misleading stale results.
  4. Report transfer (planned). Verify output object types, annotations, units, report content, destination and availability of original images.
  5. Access (planned). Verify authorized roles, audit trail, denied access and support ownership at each destination.
  6. Latency and failures (planned). Agree a workload and turnaround target; test queues, timeouts, missing results and fallback reading.
  7. Updates and rollback (planned). Define version change control, revalidation triggers, stop-use criteria and a tested rollback route.

Local implementation checklist

Agree the evidence and acceptance owner with your team and suppliers. Checkmarks apply to this page only and are not acceptance receipts.

Open the printable evaluation checklist

Deployment
The exact FDA package describes a web platform (Edge, Chrome, Firefox) in which images are pulled in from the clinic or dental office and a network layer works with the practice PACS or EMR to transmit images and metadata to Overjet. Current hosting, data flow, and commercial configuration require vendor confirmation.
  • Exact FDA submission
  • Checked 2026-11-14

Packet wording: "Platform Web - Edge, Chrome, Firefox Web - Edge, Chrome, Firefox" … "OCA is a software-only device which operates in three layers: a Network Layer, a Presentation Layer, and a Decision Layer. Images are pulled in from a clinic/dental office". Read from the exact FDA decision document on 2026-11-14; this is the release-level description, not current commercial configuration.

Integration
The network layer works with a practice PACS or EMR to transmit image and metadata to Overjet, and the web presentation layer displays annotations in a non-diagnostic viewer. The reviewed FDA packet does not establish a specific interface version, local compatibility, or current commercial deployment topology.
  • Exact FDA submission
  • Checked 2026-09-08
Security
Overjet's trust center states a completed independent HITRUST audit and certification, HIPAA business associate compliance, GDPR and CCPA alignment, third-party penetration tests, need-to-know data access and employee security training. Vendor-wide.
  • Vendor-wide
  • Checked 2026-10-25

Vendor statement, not an attestation; exact-release scope is not established.

Input or output interoperability

DICOM is explicitly referenced in the described input, output, or workflow.

exact submission · checked 2026-09-01

The model card does not establish every supported DICOM object, transfer method, or local interface.

ACR exact-submission catalog context

ACR AI Central provides an exact-submission model card for Overjet Caries Assist; FDA labeling remains controlling for clinical use, limitations, and performance.

exact submission · checked 2026-09-08
Sources & review details FDA identity, research record, source ledger, and history

Regulatory identity

FDA record and catalog context

The FDA listing establishes the regulatory identity. It does not by itself establish local workflow fit, pricing, security, or performance in your environment.

FDA submission
K222746
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31
Modality
X-ray/Radiography
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-08
Anatomy
Permanent dentition and tooth surfaces in dental/maxillofacial anatomy
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-08
Clearance type
510(k)
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31
Decision date
2023-03-27
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31
FDA status
FDA-cleared
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31

Research record

What has been checked

This audit distinguishes completed source review from fields that have not yet been researched.

Exact FDA record reviewedStatus
2026-09-20Last searched
25Fields reviewed
10Source classes checked
0Screened PubMed leads
0Screened trial leads
0Unreviewed FDA recall leads

The refreshed discovery snapshot contains no PubMed or ClinicalTrials.gov candidates; no external evidence was promoted. The current discovery snapshot contains 0 PubMed and 0 ClinicalTrials.gov candidate records; its dated, count-matched human screening remains current. Unlinked candidates remain quarantined. Native FDA recall identifiers produced 0 postmarket candidate records; 0 have been reviewed (0 published, 0 rejected) and 0 remain unreviewed.

Candidate leads were screened against the exact product and tested version. Unlinked records remain quarantined.

Source classes: fda ai list, fda decision summary, acr ai central product, vendor documentation, fda device recall, literature index, trial registry, pubmed, clinical trials, openfda device recall

Field review details

Recorded state, verification date, notes and sources for fields without a publishable value. Conflicting records stay explicitly unsettled here; no plain settled value is shown for them.

  • Public pricing: Not verified - checked 2026-09-08 - Exact FDA submission

    No public price or quote for the exact K222746 configuration was established in this review.

  • Pricing model: Not yet reviewed
  • Setup and integration fees: Not yet reviewed
  • Recurring fees: Not yet reviewed
  • Minimum commitment: Not yet reviewed
  • Contract duration: Not yet reviewed
  • Renewal terms: Not yet reviewed
  • Cancellation terms: Not yet reviewed
  • Support and service terms: Not yet reviewed
  • Trial or pilot terms: Not yet reviewed
  • Reimbursement: Not publicly available - checked 2026-09-08 - Exact FDA submission

    No exact-product payer policy, coding instruction, or payment determination was established; eligibility must be evaluated by payer, site of service, and use case.

  • Data hosting location: Not yet reviewed
  • Data retention: Not yet reviewed
  • Documented data use: Not yet reviewed
  • Hardware requirements: Not yet reviewed
  • Network requirements: Not yet reviewed
  • Identity and access: Not yet reviewed
  • Installation timeline: Not yet reviewed
  • Training: Not verified - checked 2026-09-08 - Exact FDA submission

    Current training prerequisites, competency checks, and support commitments for the exact configuration require vendor confirmation.

  • Monitoring: Not verified - checked 2026-09-08 - Exact FDA submission

    Current drift, quality, uptime, alert, escalation, and incident-response commitments for the exact configuration require vendor confirmation.

8 sources - 3 history items

Source ledger

  1. FDA K222746: Overjet Caries Assist

    U.S. Food and Drug Administration - Published 2023-03-27 - Accessed 2026-09-08

    Scope: identity, clinicalUse, modality, anatomy, workflow, evidence, implementation, deployment

  2. Artificial Intelligence-Enabled Medical Devices

    U.S. Food and Drug Administration - Accessed 2026-08-31

    Scope: regulatoryIdentity, modalityContext

  3. Overjet Caries Assist model card (K222746)

    American College of Radiology - Published 2026-08-17 - Accessed 2026-09-01

    Scope: intendedUsers, careSetting, output, reportedSensitivity, reportedSpecificity, evidenceSummary, integration, anatomy, evidenceStudies, implementationCapabilities

  4. PubMed biomedical literature index

    U.S. National Library of Medicine - Accessed 2026-09-01

    Scope: evidenceDiscovery

  5. ClinicalTrials.gov study registry

    U.S. National Library of Medicine - Accessed 2026-09-01

    Scope: evidenceDiscovery, studyStatus

  6. openFDA Device Recall API

    U.S. Food and Drug Administration - Accessed 2026-09-02

    Scope: recallDiscovery, nativeSubmissionMatching

  7. openFDA exact recall query for K222746

    U.S. Food and Drug Administration - Accessed 2026-09-08

    Scope: postmarketSafety

  8. Overjet Trust Center

    Overjet - Accessed 2026-10-25

    Scope: security

Research history

  1. K222746 FDA decision

    Regulatory record

    510(k)

  2. Source-review record updated

    Research record

    fda record reviewed

  3. Reader overview source-reviewed

    Editorial review

    Source-reviewed editorial overlay

Alternatives

Related tools to compare

FDA-cleared K250264

SugarBug (1.x)

Bench7, Inc.

Authorized purpose: Provides automated concurrent-read detection and segmentation of caries on bitewing radiographs in patients 18 and older, adding information for the dentist while requiring complete dentist review and judgment.

Modality
X-ray/Radiography
Anatomy
Dental/Maxillofacial
Decision
2025-11-07
FDA-cleared K243234

Second Opinion® CS

Pearl Inc.

Authorized purpose: Acts as a CADe second reader to detect and segment caries on periapical radiographs of permanent teeth in patients aged 12 years and older; clinicians review the contours and percentage analysis in context.

Modality
X-ray/Radiography
Anatomy
Dental/Maxillofacial
Decision
2025-06-12
FDA-cleared K242437

Smile Dx®

Cube Click, Inc.

Authorized purpose: Aids dentists reviewing bitewing and periapical radiographs of permanent teeth by detecting/segmenting caries and periapical radiolucencies, identifying restorations and dental anatomy, and measuring mesial/distal bone levels; it does not replace dentist review.

Modality
X-ray/Radiography
Anatomy
Dental/Maxillofacial
Decision
2025-05-14
FDA-cleared K233738

Overjet Caries Assist-Pediatric

Overjet, Inc

Authorized purpose: Aid dentists in detecting and segmenting caries on bitewing and periapical radiographs for patients aged 4-11 with primary or permanent teeth; the output is additional information and does not replace a complete dental review or clinical judgment.

Modality
X-ray/Radiography
Anatomy
Dental/Maxillofacial (carious tooth surfaces)
Decision
2024-03-04

Correct this exact record

Copy this public context and add the field, proposed wording and original source before sending. Nothing here is submitted automatically. Form-specific prefill has not been verified.

Open existing correction destination

Permission to display a submission is not evidence verification. A submission enters editorial review; it does not approve a public change. Form availability, data entry, receipt, review and publication are separate steps. Data entry and receipt remain unverified.

Accepted repository change history

No entry has been added to this scoped change history for this record. This is not proof that the record never changed.

Correction policy and limits · Public repository change history